Become a student member today for free and be part of the RACGP community
2021.1 RCE and 2021.2 AKT results release on 1 September and 2021.2 KFP results release on 30 September 2021.
Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP Fellowship
RACGP offer courses and events to further develop the knowledge you need to develop your GP career
Discover a world of educational opportunities to support your lifelong learning
Become a provider with the CPD Program and be recognised for the quality education and training you offer GPs
The Diabetes Handbook provides the general practice team with updated guidance and recommendations for managing type 2 diabetes
Stay up-to-date with the latest information and resources on the COVID-19 vaccine rollout.
Coronavirus is an evolving international health concern. Stay informed with the latest information.
Download the Standards for general practice (5th edition) - a benchmark for quality care and risk management in Australian general practices
Coronavirus (COVID-19) resources for general practitioners
Advice and guidelines for GPs and practice teams to help protect general practice information systems
Video consultations can provide convenient and accessible healthcare delivery
Read all of the RACGP reports and submissions on various healthcare topics
Read all of the RACGP position statements on various healthcare topics
Join our RACGP Facebook groups
Management of type 2 diabetes: A handbook for general practice
Last revised: 17 Sep 2020
Grade: A, level 1
Grade: B, level 2
Diabetic neuropathies increase with age, duration of diabetes and level of control of diabetes. They are heterogeneous, with diverse clinical manifestations, and may be focal or diffuse.
Symptoms include pain and paraesthesia, and if the autonomic nervous system is involved, gastrointestinal, bladder and sexual problems may arise. These increase the patient’s burden of self-care and overall management. Foot ulceration and amputation are important and costly sequelae of diabetic neuropathy2 (refer to the section ‘Microvascular complications: Foot care’).
Manifestations of diabetes-related peripheral neuropathy include:
Autonomic neuropathy may result in:
Before any treatment is instigated, exclusion of non-diabetic causes of neuropathy is suggested. This includes assessment for vitamin B12 deficiency, hypothyroidism and renal disease, and a review of neurotoxic drugs, including excessive alcohol consumption.
The clinical focus is on prevention via optimising glycaemic management and early recognition, facilitated by good history and routine sensory testing.
People with type 2 diabetes should be checked for diabetic peripheral neuropathy at diagnosis, and at least annually thereafter.1
Tests to assess for diabetic peripheral neuropathy are shown in Box 1. Combinations of more than one test have >87% sensitivity in detecting diabetic peripheral neuropathy. Loss of 10 g monofilament perception and reduced vibration perception predict foot ulcers.3
Several neuropathy scoring systems (diabetic neuropathy symptom score, neuropathy impairment score and Michigan neuropathy screening instrument) may be used with examination to confirm diagnosis and assess severity.4–6
Motor neuropathy sometimes occurs, with muscle wasting, weakness and abnormalities of gait. This can contribute to foot problems by altering the biomechanics of the ankle and foot.
Cardiovascular autonomic neuropathy should be suspected with resting tachycardia (>100 beats per minute) or orthostatic reduction in blood pressure (a fall in systolic blood pressure >20 mmHg on standing without an appropriate heart rate response). This applies to patients not currently on antihypertensive agents that may cause variations in blood pressure responsiveness, such as β-blockers. It is associated with increased cardiac event rates.
Management of diabetes-related neuropathy mainly involves professional assessment and foot care to prevent diabetes-associated foot disease. The appearance of peripheral neuropathy should prompt review of glycaemic control and consideration of intensified management to prevent progression.2
The pain of peripheral neuropathy can be difficult to manage, although there is evidence that several agents can improve symptom control and quality of life.
For information about the Foot Forward program to prevent amputation, contact Diabetes Australia.
Did you know you can now log your CPD with a click of a button?
Type 2 diabetes: Goals for optimum management (PDF 0.04 MB)
Australian type 2 diabetes management algorithm (PDF 0.04 MB)
Management of type 2 diabetes: A handbook for general practice - Clinical summary (PDF 0.24 MB)
Diabetes management during the coronavirus pandemic (PDF 1.53 MB)
Diabetes management during Ramadan (PDF 1.83 MB)
Emergency management of hyperglycaemia in primary care (PDF 1.44 MB)
Type 2 diabetes sick day management plan - template (DOCX 0.07 MB)
Donate to the RACGP Foundation today and influence the future of general practice